Cost-Effectiveness of Treatment Strategies for High-Risk Prostate Cancer

被引：0
|
作者：
Kowalchuk, R. O. [1 ]
Breen, W. [1 ]
Harmsen, W. S. [2 ]
Jeans, E. [3 ]
Morris, L. K. [4 ]
Mullikin, T. C. [3 ]
Miller, R. C. [5 ]
Wong, W. W. [6 ]
Vargas, C. E. [6 ]
Trifiletti, D. M. [5 ]
Phillips, R. [1 ]
Choo, C. R. [3 ]
Davis, B. J. [3 ]
Pisansky, T. M. [3 ]
Tendulkar, R. D. [7 ]
Stish, B. J. [1 ]
Waddle, M. R. [3 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Dept Biostat & Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
[4] Dept Radiat Oncol, Rochester, MN USA
[5] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL 32224 USA
[6] Mayo Clin Arizona, Dept Radiat Oncol, Phoenix, AZ USA
[7] Cleveland Clin, Taussig Canc Ctr, Dept Radiat Oncol, Cleveland, OH 44106 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2697
引用
收藏
页码：E342 / E342
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of treatment strategies for high risk prostate cancer
    Kowalchuk, Roman O.
    Kim, Hayeon
    Harmsen, William S.
    Jeans, Elizabeth B.
    Morris, Lindsay K.
    Mullikin, Trey C.
    Miller, Robert C.
    Wong, William W.
    Vargas, Carlos E.
    Trifiletti, Daniel M.
    Phillips, Ryan M.
    Choo, C. R.
    Davis, Brian J.
    Beriwal, Sushil
    Tendulkar, Rahul D.
    Stish, Bradley J.
    Breen, William G.
    Waddle, Mark R.
    [J]. CANCER, 2022, 128 (21) : 3815 - 3823
  • [2] Cost-effectiveness of prostate cancer chemoprevention among high-risk men
    Zeliadt, Steven B.
    Ramsey, Scott D.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (05) : 505 - 508
  • [3] Cost-effectiveness of antifungal strategies in high-risk neutropenic patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Kuentz, Mathieu
    Cordonnier, Catherine
    [J]. BLOOD, 2007, 110 (11) : 153B - 153B
  • [4] Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Hemery, Francois
    Kuentz, Mathieu
    Cordonnier, Catherine
    [J]. BLOOD, 2008, 112 (11) : 475 - 475
  • [5] Diagnostic and cost-effectiveness of axial skeleton MRI in staging high-risk prostate cancer
    El-Taji, Omar
    Evans, Hannah
    Arora, Vandan
    Amin, Suzanne
    Kumar, Manal
    Rajan, Thiagarajan Nambi
    [J]. BJUI COMPASS, 2023, 4 (03): : 346 - 351
  • [6] Bevacizumab in Treatment of High-Risk Ovarian Cancer-A Cost-Effectiveness Analysis
    Chan, John K.
    Herzog, Thomas J.
    Hu, Lilian
    Monk, Bradley J.
    Kiet, Tuyen
    Blansit, Kevin
    Kapp, Daniel S.
    Yu, Xinhua
    [J]. ONCOLOGIST, 2014, 19 (05): : 523 - 527
  • [7] Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals
    Benamouzig, Robert
    Barre, Stephanie
    Saurin, Jean-Christophe
    Leleu, Henri
    Vimont, Alexandre
    Taleb, Sabrine
    De Bels, Frederic
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [8] Cost-effectiveness of abiraterone acetate for high-risk nnon-metastatic prostate cancer.
    Lester-Coll, Nataniel Hernan
    Ahmed, Shahid Sattar
    Wallace, H. James
    Sprague, Brian L.
    Ades, Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [9] Cost-Effectiveness of Surveillance Strategies After Treatment for High-Grade Anal Dysplasia in High-Risk Patients
    Assoumou, Sabrina A.
    Mayer, Kenneth H.
    Panther, Lori
    Linas, Benjamin P.
    Kim, Jane
    [J]. SEXUALLY TRANSMITTED DISEASES, 2013, 40 (04) : 298 - 303
  • [10] COST-EFFECTIVENESS OF HEPATITIS-B IMMUNIZATION STRATEGIES FOR HIGH-RISK PEOPLE
    STERN, MF
    DITTUS, RS
    BIRKHEAD, G
    HUBER, R
    SCHWARTZ, J
    MORSE, D
    [J]. CLINICAL RESEARCH, 1992, 40 (02): : A568 - A568
12345